Global Information
회사소개 | 문의 | 비교리스트

심장 바이오마커 진단 키트 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측

Cardiac Biomarker Diagnostic Kits Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

리서치사 Transparency Market Research
발행일 2019년 03월 상품 코드 823557
페이지 정보 영문 190 Pages
가격
US $ 5,795 ₩ 7,234,000 PDF by E-mail (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 인쇄는 가능하지만, 전체 페이지 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 8,795 ₩ 10,979,000 PDF by E-mail (5-user License) help
5명까지 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 전체 페이지 인쇄는 1명당 1회로 한정하며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 11,795 ₩ 14,724,000 PDF by E-mail (Corporate License) help
기업 내 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


심장 바이오마커 진단 키트 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측 Cardiac Biomarker Diagnostic Kits Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026
발행일 : 2019년 03월 페이지 정보 : 영문 190 Pages

세계의 심장 바이오마커 진단 키트(Cardiac Biomarker Diagnostic Kits) 시장에 대해 조사했으며, 시장 동향과 부문별 동향, 지역별 예측, 시장에 참여하는 기업 개요에 대해 정리했습니다.

제1장 서론

제2장 가정과 조사 방법

제3장 주요 요약

제4장 시장 개요

  • 서론
  • 개요
  • 시장 역학
  • 시장 분석과 예측
  • Porter's Five Force 분석

제5장 동향

  • 규제 시나리오
  • 인수합병
  • 상환 시나리오
  • 세계적인 심장병 이환율
  • 시장의 주요 3개사

제6장 제품별 시장 분석과 예측

  • 서론과 정의
  • 주요 조사 결과/동향
  • 시장 가치 예측
    • 트로포닌 시험 키트
    • CK-MG 시험 키트
    • 미오글로빈 시험 키트
    • BNP 시험 키트
    • C 반응 단백질 시험 키트
    • 기타
  • 시장 매력도

제7장 검사별 시장 분석과 예측

  • 서론과 정의
  • 주요 조사 결과/동향
  • 시장 가치 예측
    • 시험기관 검사
    • POC(Pont-of-care) 검사
  • 시장 매력도

제8장 질환 적응별 시장 분석과 예측

  • 서론과 정의
  • 주요 조사 결과/동향
  • 시장 가치 예측
    • AngiStent 타입 협심증
    • 심근경색
    • 심부전
    • 기타
  • 시장 매력도

제9장 최종사용자별 시장 분석과 예측

  • 서론과 정의
  • 주요 조사 결과/동향
  • 시장 가치 예측
    • 병원
    • 클리닉
    • 진단 시험기관
    • 기타
  • 시장 매력도

제10장 지역별 시장 분석과 예측

  • 주요 조사 결과
  • 시장 가치 예측
    • 북미
    • 유럽
    • 아시아태평양
    • 라틴아메리카
    • 중동 및 아프리카
  • 시장 매력도

제11장 북미 시장

제12장 유럽 시장

제13장 아시아태평양 시장

제14장 라틴아메리카 시장

제15장 중동 및 아프리카 시장

제16장 경쟁 상황

  • 경쟁 매트릭스
  • 시장 점유율 분석
  • 경쟁 비지니스 전략
  • 기업 개요
KSM 19.04.25

List of Tables

  • Table 01: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Product, 2016-2026
  • Table 02: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Disease Indication, 2016-2026
  • Table 03: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Testing, 2016-2026
  • Table 04: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 05: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Region, 2016-2026
  • Table 06: North America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Product, 2016-2026
  • Table 07: North America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Disease Indication, 2016-2026
  • Table 08: North America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Testing, 2016-2026
  • Table 09: North America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 10: North America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Country, 2016-2026
  • Table 11: Europe Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Product, 2016-2026
  • Table 12: Europe Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Disease Indication, 2016-2026
  • Table 13: Europe Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Testing, 2016-2026
  • Table 14: Europe Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 15: Europe Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016-2026
  • Table 16: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Product, 2016-2026
  • Table 17: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Disease Indication, 2016-2026
  • Table 18: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Testing, 2016-2026
  • Table 19: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 20: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016-2026
  • Table 21: Latin America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Product, 2016-2026
  • Table 22: Latin America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Disease Indication, 2016-2026
  • Table 23: Latin America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Testing, 2016-2026
  • Table 24: Latin America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 25: Latin America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016-2026
  • Table 26: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Product, 2016-2026
  • Table 27: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Disease Indication, 2016-2026
  • Table 28: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Testing, 2016-2026
  • Table 29: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 30: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016-2026

List of Figures

  • Figure 01: Global Cardiac Biomarker Diagnostic Kits Market Value Share, by Product, 2017 and 2026
  • Figure 02: Global Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Product, 2018-2026
  • Figure 03: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth (%), by Troponin Test Kits, 2016-2026
  • Figure 04: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth (%), by CK-MB Test Kits, 2016-2026
  • Figure 05: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth (%), by Myoglobin Test Kits, 2016-2026
  • Figure 06: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth (%), by BNP Test Kit, 2016-2026
  • Figure 07: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth (%), by C-reactive Protein (hsCRP), 2016-2026
  • Figure 08: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth (%), by Other Biomarkers, 2016-2026
  • Figure 09: Global Cardiac Biomarker Diagnostic Kits Market Value Share, by Disease Indication, 2017 and 2026
  • Figure 10: Global Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Disease Indication, 2018-2026
  • Figure 11: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth (%), by Angina Pectoris, 2016-2026
  • Figure 12: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth (%), by Myocardial Infraction (MI), 2016-2026
  • Figure 13: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth (%), by Cardiac Heart Failure, 2016-2026
  • Figure 14: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth (%), by Others, 2016-2026
  • Figure 15: Global Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by Testing, 2017 and 2026
  • Figure 16: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth, by Laboratory Testing, 2016-2026
  • Figure 17: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth, by Pont-of-care testing, 2016-2026
  • Figure 18: Global Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by Testing, 2018-2026
  • Figure 19: Global Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by End-user, 2017 and 2026
  • Figure 20: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth, by Hospitals, 2016-2026
  • Figure 21: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth, by Clinics, 2016-2026
  • Figure 22: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth, by Diagnostic Laboratory, 2016-2026
  • Figure 23: Global Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by End-user, 2018-2026
  • Figure 24: Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by Region, 2017 and 2026
  • Figure 25: Global Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis by Region, 2018-2026
  • Figure 26: North America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016-2026
  • Figure 27: North America Cardiac Biomarker Diagnostic Kits Market Value Share, by Product, 2017 and 2026
  • Figure 28: North America Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Product, 2018-2026
  • Figure 29: North America Cardiac Biomarker Diagnostic Kits Market Value Share, by Disease Indication, 2017 and 2026
  • Figure 30: North America Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Disease Indication, 2018-2026
  • Figure 31: North America Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by Testing, 2017 and 2026
  • Figure 32: North America Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by Testing, 2018-2026
  • Figure 33: North America Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by End-user, 2017 and 2026
  • Figure 34: North America Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by End-user, 2018-2026
  • Figure 35: North America Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by Country, 2018-2026
  • Figure 36: North America Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by Country, 2017 and 2026
  • Figure 37: Europe Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016-2026
  • Figure 38: Europe Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by Testing, 2017 and 2026
  • Figure 39: Europe Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by Testing, 2018-2026
  • Figure 40: Europe Cardiac Biomarker Diagnostic Kits Market Value Share, by Product, 2017 and 2026
  • Figure 41: Europe Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Product, 2018-2026
  • Figure 42: Europe Cardiac Biomarker Diagnostic Kits Market Value Share, by Disease Indication, 2017 and 2026
  • Figure 43: Europe Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Disease Indication, 2018-2026
  • Figure 44: Europe Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by End-user, 2017 and 2026
  • Figure 45: Europe Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by End-user, 2018-2026
  • Figure 46: Europe Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by Country/Sub-region, 2018-2026
  • Figure 47: Europe Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
  • Figure 48: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016-2026
  • Figure 49: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value Share, by Product, 2017 and 2026
  • Figure 50: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Product, 2018-2026
  • Figure 51: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value Share, by Disease Indication, 2017 and 2026
  • Figure 52: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Disease Indication, 2018-2026
  • Figure 53: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by Testing, 2017 and 2026
  • Figure 54: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by Testing, 2018-2026
  • Figure 55: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by End-user, 2017 and 2026
  • Figure 56: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by End-user, 2018-2026
  • Figure 57: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by Country/Sub-region, 2018-2026
  • Figure 58: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
  • Figure 59: Latin America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016-2026
  • Figure 60: Latin America Cardiac Biomarker Diagnostic Kits Market Value Share, by Product, 2017 and 2026
  • Figure 61: Latin America Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Product, 2018-2026
  • Figure 62: Latin America Cardiac Biomarker Diagnostic Kits Market Value Share, by Disease Indication, 2017 and 2026
  • Figure 63: Latin America Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Disease Indication, 2018-2026
  • Figure 64: Latin America Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by Testing, 2017 and 2026
  • Figure 65: Latin America Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by Testing, 2018-2026
  • Figure 66: Latin America Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by End-user, 2017 and 2026
  • Figure 67: Latin America Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by End-user, 2018-2026
  • Figure 68: Latin America Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by Country/Sub-region, 2018-2026
  • Figure 69: Latin America Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
  • Figure 70: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016-2026
  • Figure 71: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value Share, by Product, 2017 and 2026
  • Figure 72: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Product, 2018-2026
  • Figure 73: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value Share, by Disease Indication, 2017 and 2026
  • Figure 74: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Disease Indication, 2018-2026
  • Figure 75: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by Testing, 2017 and 2026
  • Figure 76: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by Testing, 2018-2026
  • Figure 77: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by End-user, 2017 and 2026
  • Figure 78: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by End-user, 2018-2026
  • Figure 79: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by Country, 2018-2026
  • Figure 80: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by Country, 2017 and 2026

Title:
Cardiac Biomarker Diagnostic Kits Market (Product - Troponin Test Kits, CK-MB Test Kits, Myoglobin Test Kits, BNP Test Kit, C-reactive Protein (hsCRP), Other Biomarkers; Disease Indication - Angina Pectoris, Myocardial Infraction (MI), Cardiac Heart Failure; Testing - Laboratory Testing, Point of Care Testing; End user - Hospitals, Clinics, Diagnostics Centers) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026.

Overview

This report on the global cardiac biomarker diagnostic kits market comprises an elaborate executive summary, including a market snapshot that provides information about various segments of the market. The report also provides information and data analysis of the global market with respect to its segments based on disease indication, product, testing, and end-user. A detailed qualitative analysis of drivers, restraints, and opportunities of the market has been provided in the market overview section. Additionally, the section comprises a competitive matrix and company profiles with business overview to project the competitive landscape of the market. It also provides market attractiveness analysis in terms of region and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario prevailing in the global cardiac biomarker diagnostic kits market.

Key Segments

Based on disease indication, the global cardiac biomarker diagnostic kits market has been segmented into angina pectoris, myocardial infraction, cardiac heart failure, and others. In terms of testing, the market has been classified into laboratory testing and point of care testing. In terms of product, the market has been classified into troponin test kits, CK-MB test kits, myoglobin test kits, BNP Test Kit, C-reactive Protein (hsCRP), and other biomarkers. Based on end-user, the market has been categorized into hospitals, clinics, diagnostics centers, and others. The global cardiac biomarker diagnostic kits market has been analyzed based on increasing regulatory scrutiny, technology trends, expenditure on emerging technologies and presence of key players in the region. Market size and forecast for each of these segments have been provided for the period of 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

Regional Outlook

In terms of region, the global cardiac biomarker diagnostic kits market has been categorized into five major regions and key countries in these regions: North America (the U.S., Canada), Europe (the U.K., Germany, France, Italy, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (GCC, South Africa, and Rest of Middle East & Africa). Market size and forecast for each of these regions and their key countries have been provided for the period of 2016 to 2026, along with their respective CAGRs for the forecast period 2018-2026, considering 2017 as the base year.

Companies Mentioned in the Report

The report profiles major players operating in the global Cardiac Biomarker Diagnostic Kits market in terms of attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major companies profiled in this report include Abbott Laboratories, Hoffmann-La Roche AG, Bio-Rad Laboratories, Danaher Corporation, Seimens Healthineers, Thermofisher Scientific, bioMerieux, Randox Laboratories Ltd., and Ortho Clinical Diagnostics.

The global cardiac biomarker diagnostic kits market has been segmented as follows:

Global Cardiac Biomarker Diagnostic Kits Market, by Disease Indication

  • Angina pectoris
  • Myocardial Infraction (MI)
  • Cardiac Heart Failure
  • Others

Global Cardiac Biomarker Diagnostic Kits Market, by Product

  • Troponin Test Kits
    • CK-MB Test Kits
    • Myoglobin Test Kits
    • BNP Test Kit
    • C-reactive Protein (hsCRP)
    • Other Biomarkers (galectin-3, H-FABP, myeloperoxidase, ischemia-modified albumin, and homocysteine)
  • Global Cardiac Biomarker Diagnostic Kits Market, Testing
    • Laboratory Testing
    • Pont-of-care Testing

Global Cardiac Biomarker Diagnostic Kits Market, by End-user

  • Hospitals
  • Clinics
  • Diagnostic Centers
  • Others

Global Cardiac Biomarker Diagnostic Kits Market, by Region

  • North America
    • U.S
    • Canada
  • Europe
    • Germany
    • U.K
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • Australia & New Zealand
    • India
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Cardiac Biomarker Diagnostic Kits Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Products Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast, 2016-2026
    • 4.4.1. Market Revenue Projections (US$ Mn)
  • 4.5. Porter's Five Force Analysis

5. Key Insights

  • 5.1. Regulatory Scenario by Region/Globally
  • 5.2. Key Mergers & Acquisitions
  • 5.3. Reimbursement Scenario
  • 5.4. Cardiac Diseases Prevalence Rate Globally with Key Countries
  • 5.5. Top 3 players operating in the market space

6. Global Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast, by Product

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Global Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Product, 2016-2026
    • 6.3.1. Troponin Test Kits
    • 6.3.2. CK-MB Test Kits
    • 6.3.3. Myoglobin Test Kits
    • 6.3.4. BNP Test Kit
    • 6.3.5. C-reactive Protein (hsCRP)
    • 6.3.6. Others
  • 6.4. Global Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Product

7. Global Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast, by Testing

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Global Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Testing, 2016-2026
    • 7.3.1. Laboratory Testing
    • 7.3.2. Pont-of-care Testing
  • 7.4. Global Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Testing

8. Global Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast, by Disease Indication

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Global Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Disease Indication, 2016-2026
    • 8.3.1. AngiStent Type Pectoris
    • 8.3.2. Myocardial Infraction
    • 8.3.3. Cardiac Heart Failure
    • 8.3.4. Other
  • 8.4. Global Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Disease Indication

9. Global Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast, by End-user

  • 9.1. Introduction & Definition
  • 9.2. Key Findings / Developments
  • 9.3. Global Cardiac Biomarker Diagnostic Kits Market Value Forecast, by End-user, 2016-2026
    • 9.3.1. Hospitals
    • 9.3.2. Clinics
    • 9.3.3. Diagnostic Laboratory
    • 9.3.4. Others
  • 9.4. Global Cardiac Biomarker Diagnostic Kits Market Attractiveness, by End-user

10. Global Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Global Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Region
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Global Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Region

11. North America Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. North America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Product, 2016-2026
    • 11.2.1. Troponin Test Kits
    • 11.2.2. CK-MB Test Kits
    • 11.2.3. Myoglobin Test Kits
    • 11.2.4. BNP Test Kit
    • 11.2.5. C-reactive Protein (hsCRP)
    • 11.2.6. Others
  • 11.3. North America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Testing, 2016-2026
    • 11.3.1. Laboratory Testing
    • 11.3.2. Pont-of-care Testing
  • 11.4. North America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Disease Indication, 2016-2026
    • 11.4.1. AngiStent Type Pectoris
    • 11.4.2. Myocardial Infraction
    • 11.4.3. Cardiac Heart Failure
    • 11.4.4. Other
  • 11.5. North America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by End-user, 2016-2026
    • 11.5.1. Hospitals
    • 11.5.2. Clinics
    • 11.5.3. Diagnostic Laboratory
    • 11.5.4. Others
  • 11.6. North America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Country, 2016-2026
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. North America Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis
    • 11.7.1. By Product
    • 11.7.2. By Testing
    • 11.7.3. By Disease Indication
    • 11.7.4. By End-user
    • 11.7.5. By Country

12. Europe Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Europe Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Product, 2016-2026
    • 12.2.1. Troponin Test Kits
    • 12.2.2. CK-MB Test Kits
    • 12.2.3. Myoglobin Test Kits
    • 12.2.4. BNP Test Kit
    • 12.2.5. C-reactive Protein (hsCRP)
    • 12.2.6. Others
  • 12.3. Europe Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Testing, 2016-2026
    • 12.3.1. Laboratory Testing
    • 12.3.2. Pont-of-care Testing
  • 12.4. Europe Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Disease Indication, 2016-2026
    • 12.4.1. AngiStent Type Pectoris
    • 12.4.2. Myocardial Infraction
    • 12.4.3. Cardiac Heart Failure
    • 12.4.4. Other
  • 12.5. Europe Cardiac Biomarker Diagnostic Kits Market Value Forecast, by End-user, 2016-2026
    • 12.5.1. Hospitals
    • 12.5.2. Clinics
    • 12.5.3. Diagnostic Laboratory
    • 12.5.4. Others
  • 12.6. Europe Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Country/Sub-region, 2016-2026
    • 12.6.1. Germany
    • 12.6.2. U.K.
    • 12.6.3. France
    • 12.6.4. Spain
    • 12.6.5. Italy
    • 12.6.6. Rest of Europe
  • 12.7. Europe Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis
    • 12.7.1. By Product
    • 12.7.2. By Testing
    • 12.7.3. by Disease Indication
    • 12.7.4. by End-user
    • 12.7.5. by Country/Sub-region

13. Asia Pacific Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Product, 2016-2026
    • 13.2.1. Troponin Test Kits
    • 13.2.2. CK-MB Test Kits
    • 13.2.3. Myoglobin Test Kits
    • 13.2.4. BNP Test Kit
    • 13.2.5. C-reactive Protein (hsCRP)
    • 13.2.6. Others
  • 13.3. Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Testing, 2016-2026
    • 13.3.1. Laboratory Testing
    • 13.3.2. Pont-of-care Testing
  • 13.4. Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Disease Indication, 2016-2026
    • 13.4.1. AngiStent Type Pectoris
    • 13.4.2. Myocardial Infraction
    • 13.4.3. Cardiac Heart Failure
    • 13.4.4. Other
  • 13.5. Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value Forecast, by End-user, 2016-2026
    • 13.5.1. Hospitals
    • 13.5.2. Clinics
    • 13.5.3. Diagnostic Laboratory
    • 13.5.4. Others
  • 13.6. Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Country/Sub-region, 2016-2026
    • 13.6.1. China
    • 13.6.2. Japan
    • 13.6.3. India
    • 13.6.4. Australia & New Zealand
    • 13.6.5. Rest of Asia Pacific
  • 13.7. Asia Pacific Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis
    • 13.7.1. By Product
    • 13.7.2. By Testing
    • 13.7.3. By Disease Indication
    • 13.7.4. By End-user
    • 13.7.5. By Country/Sub-region

14. Latin America Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Latin America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Product, 2016-2026
    • 14.2.1. Troponin Test Kits
    • 14.2.2. CK-MB Test Kits
    • 14.2.3. Myoglobin Test Kits
    • 14.2.4. BNP Test Kit
    • 14.2.5. C-reactive Protein (hsCRP)
    • 14.2.6. Others
  • 14.3. Latin America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Testing, 2016-2026
    • 14.3.1. Laboratory Testing
    • 14.3.2. Pont-of-care Testing
  • 14.4. Latin America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Disease Indication, 2016-2026
    • 14.4.1. AngiStent Type Pectoris
    • 14.4.2. Myocardial Infraction
    • 14.4.3. Cardiac Heart Failure
    • 14.4.4. Other
  • 14.5. Latin America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by End-user, 2016-2026
    • 14.5.1. Hospitals
    • 14.5.2. Clinics
    • 14.5.3. Diagnostic Laboratory
    • 14.5.4. Others
  • 14.6. Latin America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Country/Sub-region, 2016-2026
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Rest of Latin America
  • 14.7. Latin America Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis
    • 14.7.1. By Product
    • 14.7.2. By Testing
    • 14.7.3. By Disease Indication
    • 14.7.4. By End-user
    • 14.7.5. By Country/Sub-region

15. Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Product, 2016-2026
    • 15.2.1. Troponin Test Kits
    • 15.2.2. CK-MB Test Kits
    • 15.2.3. Myoglobin Test Kits
    • 15.2.4. BNP Test Kit
    • 15.2.5. C-reactive Protein (hsCRP)
    • 15.2.6. Others
  • 15.3. Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Testing, 2016-2026
    • 15.3.1. Laboratory Testing
    • 15.3.2. Pont-of-care Testing
  • 15.4. Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Disease Indication, 2016-2026
    • 15.4.1. AngiStent Type Pectoris
    • 15.4.2. Myocardial Infraction
    • 15.4.3. Cardiac Heart Failure
    • 15.4.4. Other
  • 15.5. Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value Forecast, by End-user, 2016-2026
    • 15.5.1. Hospitals
    • 15.5.2. Clinics
    • 15.5.3. Diagnostic Laboratory
    • 15.5.4. Others
  • 15.6. Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Country/Sub-region, 2016-2026
    • 15.6.1. GCC Countries
    • 15.6.2. South Africa
    • 15.6.3. Rest of Middle East & Africa
  • 15.7. Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis
    • 15.7.1. By Product
    • 15.7.2. By Testing
    • 15.7.3. By Disease Indication
    • 15.7.4. By End-user
    • 15.7.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (by Tier and Size of companies)
  • 16.2. Market Share Analysis by Company (2017)
  • 16.3. Competitive Business Strategies
  • 16.4. Company Profiles
    • 16.4.1. Abbott Laboratories Ltd.
      • 16.4.1.1. Company Overview (Headquarters, Business Segments, Employee Strength)
      • 16.4.1.2. Business Overview
      • 16.4.1.3. Product Portfolio
      • 16.4.1.4. Financial Overview
      • 16.4.1.5. SWOT Analysis
    • 16.4.2. Hoffmann-La Roche AG
      • 16.4.2.1. Company Overview (Headquarters, Business Segments, Employee Strength)
      • 16.4.2.2. Business Overview
      • 16.4.2.3. Product Portfolio
      • 16.4.2.4. Financial Overview
      • 16.4.2.5. SWOT Analysis
    • 16.4.3. Bio-Rad Laboratories
      • 16.4.3.1. Company Overview (Headquarters, Business Segments, Employee Strength)
      • 16.4.3.2. Business Overview
      • 16.4.3.3. Product Portfolio
      • 16.4.3.4. Financial Overview
      • 16.4.3.5. SWOT Analysis
    • 16.4.4. Danaher Corporation
      • 16.4.4.1. Company Overview (Headquarters, Business Segments, Employee Strength)
      • 16.4.4.2. Business Overview
      • 16.4.4.3. Product Portfolio
      • 16.4.4.4. Financial Overview
      • 16.4.4.5. SWOT Analysis
    • 16.4.5. Seimens Healthineers
      • 16.4.5.1. Company Overview (Headquarters, Business Segments, Employee Strength)
      • 16.4.5.2. Business Overview
      • 16.4.5.3. Product Portfolio
      • 16.4.5.4. Financial Overview
      • 16.4.5.5. SWOT Analysis
    • 16.4.6. Thermofisher Scientific
      • 16.4.6.1. Company Overview (Headquarters, Business Segments, Employee Strength)
      • 16.4.6.2. Business Overview
      • 16.4.6.3. Product Portfolio
      • 16.4.6.4. Financial Overview
      • 16.4.6.5. SWOT Analysis
    • 16.4.7. bioMerieux
      • 16.4.7.1. Company Overview (Headquarters, Business Segments, Employee Strength)
      • 16.4.7.2. Business Overview
      • 16.4.7.3. Product Portfolio
      • 16.4.7.4. Financial Overview
      • 16.4.7.5. SWOT Analysis
    • 16.4.8. Ortho Clinical Diagnostics
      • 16.4.8.1. Company Overview (Headquarters, Business Segments, Employee Strength)
      • 16.4.8.2. Business Overview
      • 16.4.8.3. Product Portfolio
      • 16.4.8.4. Financial Overview
      • 16.4.8.5. SWOT Analysis
Back to Top
전화 문의
F A Q